Professor Faghy (Far-he) leads the COVID-19/Long COVID research group at the University of Derby (UK) and has an established record in designing and delivering research projects to increase the understanding of COVID-19 sequalae and the wider impacts upon functional status and quality of life. Professor Faghy led the University of Derby Long COVID research team to success in attaining the 2024 Nature Inclusive Health Research Award, for their project ‘Profiling the Determinants of Long COVID’. In addition to leading several clinical investigations, Professor Faghy has integrated qualitative and mixed-methods approaches into his research to capture the lived experiences of individuals—an essential aspect of advancing knowledge and shaping effective responses to the pandemic. This has resulted in several compelling outputs, such as publications in high-impact journals and policy briefs. Professor Faghy has delivered the UKs’ first Phase 1 trial in intravenous antiviral therapy, an exciting step forward towards finding meaningful treatments for patients with Long COVID. Professor Faghy’s team are based within the Biomedical and Clinical Exercise Science group at the University of Derby, the COVID-19/Long COVID research group is supported by academics with extensive expertise in clinical research on chronic diseases and a commitment to translating research into real-world outcomes that enhance patient care.